Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: Characterization, metabolism, and interconversion

Molecular Nutrition and Food Research

Volumn 56, Issue 11, 2012, Pages 1675-1687

  Abbaoui, Besma ^a   Riedl, Kenneth M ^a   Ralston, Robin A ^a   Thomas Ahner, Jennifer M ^a   Schwartz, Steven J ^a   Clinton, Steven K ^a   Mortazavi, Amir ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bladder cancer; Broccoli; Erucin; Isothiocyanates; Sulforaphane

Indexed keywords

ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; ERUCIN; GLUCOSINOLATE; INHIBITOR OF APOPTOSIS PROTEIN; PLANT EXTRACT; SULFIDE; SULFORAFAN; THIOCYANIC ACID DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; BLADDER TUMOR; BRASSICA; CELL CYCLE CHECKPOINT; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BRASSICA; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; FEMALE; GLUCOSINOLATES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, NUDE; PLANT EXTRACTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SULFIDES; THIOCYANATES; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

BRASSICA OLERACEA VAR. ITALICA; MURINAE;

EID: 84867938453     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200276     Document Type: Article

References (50)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J. et al., Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
2. Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B. et al., The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003, 21, 1315-1330.
3. Guindon, G. E., Boisclair, D., Past, Current and Future Trends in Tobacco Use. WHO Tobacco Control Papers, Center for Tobacco Control Research and Education, UC San Francisco http://escholarship.org/uc/item/4q57d5vp 2003.
4. Augustine, A., Hebert, J. R., Kabat, G. C., Wynder, E. L., Bladder cancer in relation to cigarette smoking. Cancer Res. 1988, 48, 4405-4408.
5. Crawford, J. M., The origins of bladder cancer. Lab. Invest. 2008, 88, 686-693.
6. Wu, X. R., Urothelial tumorigenesis: a tale of divergent pathways. Nat. Rev. Cancer 2005, 5, 713-725.
7. Jacobs, B. L., Lee, C. T., Montie, J. E., Bladder cancer in 2010: how far have we come? CA Cancer J. Clin. 2010, 60, 244-272.
8. Michaud, D. S., Spiegelman, D., Clinton, S. K., Rimm, E. B. et al., Fluid intake and the risk of bladder cancer in men. N. Engl. J. Med. 1999, 340, 1390-1397.
9. Michaud, D. S., Spiegelman, D., Clinton, S. K., Rimm, E. B. et al., Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J. Natl. Cancer Inst. 1999, 91, 605-613.
10. Michaud, D. S., Spiegelman, D., Clinton, S. K., Rimm, E. B. et al., Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am. J. Epidemiol. 2000, 152, 1145-1153.
11. Michaud, D. S., Clinton, S. K., Rimm, E. B., Willett, W. C. et al., Risk of bladder cancer by geographic region in a U.S. cohort of male health professionals. Epidemiology 2001, 12, 719-726.
12. Tang, L., Zirpoli, G. R., Guru, K., Moysich, K. B. et al., Intake of cruciferous vegetables modifies bladder cancer survival. Cancer Epidemiol. Biomarkers Prev. 2010, 19, 1806-1811.
13. Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K. et al., Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol. Biomarkers Prev. 2001, 10, 501-508.
14. Fahey, J. W., Zhang, Y., Talalay, P., Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. USA 1997, 94, 10367-10372.
15. Wu, X., Zhou, Q. H., Xu, K., Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol. Sin. 2009, 30, 501-512.
16. Hecht, S. S., Inhibition of carcinogenesis by isothiocyanates. Drug Metab. Rev. 2000, 32, 395-411.
17. Zhang, Y., Talalay, P., Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res. 1994, 54, 1976s-1981s.
18. Munday, R., Mhawech-Fauceglia, P., Munday, C. M., Paonessa, J. D. et al., Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res. 2008, 68, 1593-1600.
19. Ding, Y., Paonessa, J. D., Randall, K. L., Argoti, D. et al., Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues. Carcinogenesis 2010, 31, 1999-2003.
20. Bhattacharya, A., Tang, L., Li, Y., Geng, F. et al., Inhibition of bladder cancer development by allyl isothiocyanate. Carcinogenesis 2010, 31, 281-286.
21. Duggan, B. J., Gray, S. B., McKnight, J. J., Watson, C. J. et al., Oligoclonality in bladder cancer: the implication for molecular therapies. J. Urol. 2004, 171, 419-425.
22. Lamy, E., Scholtes, C., Herz, C., Mersch-Sundermann, V., Pharmacokinetics and pharmacodynamics of isothiocyanates. Drug Metab. Rev. 2011, 43, 387-407.
23. Egner, P. A., Kensler, T. W., Chen, J. G., Gange, S. J. et al., Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. Chem Res. Toxicol. 2008, 21, 1991-1996.
24. Clarke, J. D., Hsu, A., Williams, D. E., Dashwood, R. H. et al., Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type Mice. Pharm. Res. 2011, 28, 3171-3179.
25. Mellon, F. A., Bennett, R. N., Holst, B., Williamson, G., Intact glucosinolate analysis in plant extracts by programmed cone voltage electrospray LC/MS: performance and comparison with LC/MS/MS methods. Anal. Biochem. 2002, 306, 83-91.
26. Tian, Q., Rosselot, R. A., Schwartz, S. J., Quantitative determination of intact glucosinolates in broccoli, broccoli sprouts, Brussels sprouts, and cauliflower by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Anal. Biochem. 2005, 343, 93-99.
27. Zhou, J. R., Gugger, E. T., Tanaka, T., Guo, Y. et al., Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr. 1999, 129, 1628-1635.
28. Wang, S., DeGroff, V. L., Clinton, S. K., Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J. Nutr. 2003, 133, 2367-2376.
29. Vermeulen, M., Zwanenburg, B., Chittenden, G. J. F., Verhagen, H., Synthesis of isothiocyanate-derived mercapturic acids. Eur. J. Med. Chem. 2003, 38, 729-737.
30. Al Janobi, A. A., Mithen, R. F., Gasper, A. V., Shaw, P. N. et al., Quantitative measurement of sulforaphane, iberin and their mercapturic acid pathway metabolites in human plasma and urine using liquid chromatography-tandem electrospray ionisation mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2006, 844, 223-234.
31. Rosenblatt, R., Jonmarker, S., Lewensohn, R., Egevad, L. et al., Current status of prognostic immunohistochemical markers for urothelial bladder cancer. Tumour Biol. 2008, 29, 311-322.
32. Bellmunt, J., Hussain, M., Dinney, C. P., Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family. Crit. Rev. Oncol. Hematol. 2003, 46, S85-S104.
33. Myzak, M. C., Tong, P., Dashwood, W. M., Dashwood, R. H. et al., Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp. Biol. Med. 2007, 232, 227-234.
34. Singh, A. V., Xiao, D., Lew, K. L., Dhir, R. et al., Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 2004, 25, 83-90.
35. Munday, R., Munday, C. M., Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds. J. Agric. Food Chem. 2004, 52, 1867-1871.
36. Fahey, J. W., Zalcmann, A. T., Talalay, P., The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001, 56, 5-51.
37. Shan, Y., Sun, C., Zhao, X., Wu, K. et al., Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells. Int. J. Oncol. 2006, 29, 883-888.
38. Tang, L., Zhang, Y., Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol. Cancer Ther. 2005, 4, 1250-1259.
39. Tang, L., Zhang, Y., Jobson, H. E., Li, J. et al., Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol. Cancer Ther. 2006, 5, 935-944.
40. Buckley, M. T., Yoon, J., Yee, H., Chiriboga, L. et al., The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo. J. Transl. Med. 2007, 5, 49.
41. Wu, X. R., Lin, J. H., Walz, T., Haner, M. et al., Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J. Biol. Chem. 1994, 269, 13716-13724.
42. Zhang, Z. T., Pak, J., Huang, H. Y., Shapiro, E. et al., Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene 2001, 20, 1973-1980.
43. Melchini, A., Traka, M. H., Biological profile of erucin: a new promising anticancer agent from cruciferous vegetables. Toxins 2010, 2, 593-612.
44. Conaway, C. C., Getahun, S. M., Liebes, L. L., Pusateri, D. J. et al., Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer 2000, 38, 168-178.
45. Clarke, J. D., Hsu, A., Riedl, K., Bella, D. et al., Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol. Res. 2011, 64, 456-463.
46. Conaway, C. C., Krzeminski, J., Amin, S., Chung, F. L., Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes. Chem. Res. Toxicol. 2001, 14, 1170-1176.
47. Tang, L., Li, G., Song, L., Zhang, Y., The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs 2006, 17, 297-305.
48. Kassahun, K., Davis, M., Hu, P., Martin, B. et al., Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates. Chem. Res. Toxicol. 1997, 10, 1228-1233.
49. Bheemreddy, R. M., Jeffery, E. H., The metabolic fate of purified glucoraphanin in F344 rats. J. Agric. Food Chem. 2007, 55, 2861-2866.
50. Vermeulen, M., van den Berg, R., Freidig, A. P., van Bladeren, P. J. et al., Association between consumption of cruciferous vegetables and condiments and excretion in urine of isothiocyanate mercapturic acids. J. Agric. Food Chem. 2006, 54, 5350-5358.